S. Mccroskery

发表

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

S. Lamola, M. Lal, P. Pitisuttithum, 2022, eClinicalMedicine.

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

A. García-Sastre, P. Palese, I. González-Domínguez, 2021, Nature Communications.

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

S. Lamola, M. Lal, P. Pitisuttithum, 2021, medRxiv.

A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters

A. García-Sastre, P. Palese, I. González-Domínguez, 2021, bioRxiv.

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

A. García-Sastre, P. Palese, I. González-Domínguez, 2022, Microbiology spectrum.

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice

A. García-Sastre, P. Palese, I. González-Domínguez, 2022, bioRxiv.

Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines

P. Palese, S. McCroskery, G. Vijayakumar, 2019, Journal of Virology.

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

R. Baric, A. García-Sastre, P. Palese, 2020, EBioMedicine.

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

R. Baric, A. García-Sastre, P. Palese, 2020, bioRxiv.

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

R. Baric, R. Albrecht, A. García-Sastre, 2020, Vaccines.

Things We Do for No Reason™: Routine preoperative hemostatic testing for neurosurgical procedures.

S. McCroskery, Surafel Tsega, Helen Liu, 2022, Journal of hospital medicine.

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

R. Baric, R. Albrecht, A. García-Sastre, 2020, bioRxiv.

Newcastle disease virus ( NDV ) expressing the spike protein of SARS-CoV-2 as vaccine candidate 1 2

R. Baric, A. García-Sastre, P. Palese, 2020 .